Bob Lubamba

497 total citations
15 papers, 389 citations indexed

About

Bob Lubamba is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Genetics. According to data from OpenAlex, Bob Lubamba has authored 15 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 2 papers in Genetics. Recurrent topics in Bob Lubamba's work include Cystic Fibrosis Research Advances (12 papers), Asthma and respiratory diseases (4 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Bob Lubamba is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Asthma and respiratory diseases (4 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Bob Lubamba collaborates with scholars based in Belgium, United States and Netherlands. Bob Lubamba's co-authors include Teresinha Leal, Sabrina Noël, Carla M. P. Ribeiro, Jean Lebacq, Patrick Lebecque, Pierre Wallemacq, Wanda K. O’Neal, Lisa C. Jones, Richard C. Boucher and Hugo de Jonge and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Advanced Drug Delivery Reviews and International Journal of Molecular Sciences.

In The Last Decade

Bob Lubamba

15 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bob Lubamba Belgium 9 272 120 70 45 44 15 389
Daniel P. Cook United States 9 202 0.7× 126 1.1× 84 1.2× 26 0.6× 34 0.8× 17 369
Puay-Wah Phuan United States 11 416 1.5× 374 3.1× 94 1.3× 24 0.5× 35 0.8× 13 750
Furong Yan China 12 90 0.3× 267 2.2× 109 1.6× 25 0.6× 21 0.5× 29 454
Patryk Szulakowski United Kingdom 4 156 0.6× 200 1.7× 74 1.1× 9 0.2× 29 0.7× 6 411
Hiro Matsui United States 4 198 0.7× 292 2.4× 45 0.6× 21 0.5× 38 0.9× 5 615
Mary Abigail S. Garcia United States 4 182 0.7× 118 1.0× 38 0.5× 8 0.2× 6 0.1× 6 308
Chih-Ru Lin United States 10 89 0.3× 160 1.3× 47 0.7× 13 0.3× 18 0.4× 14 322
Abdullah Akbar Canada 8 214 0.8× 69 0.6× 50 0.7× 25 0.6× 30 0.7× 9 326
Maria Pantelidou Cyprus 11 79 0.3× 165 1.4× 36 0.5× 12 0.3× 27 0.6× 24 395

Countries citing papers authored by Bob Lubamba

Since Specialization
Citations

This map shows the geographic impact of Bob Lubamba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Lubamba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Lubamba more than expected).

Fields of papers citing papers by Bob Lubamba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bob Lubamba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Lubamba. The network helps show where Bob Lubamba may publish in the future.

Co-authorship network of co-authors of Bob Lubamba

This figure shows the co-authorship network connecting the top 25 collaborators of Bob Lubamba. A scholar is included among the top collaborators of Bob Lubamba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bob Lubamba. Bob Lubamba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Izadifar, Zohreh, Alexandra Sontheimer-Phelps, Bob Lubamba, et al.. (2022). Modeling mucus physiology and pathophysiology in human organs-on-chips. Advanced Drug Delivery Reviews. 191. 114542–114542. 20 indexed citations
2.
3.
Davis, Eric S., Arunava Ghosh, Raymond D. Coakley, et al.. (2021). Chronic E-Cigarette Exposure Alters Human Alveolar Macrophage Morphology and Gene Expression. Nicotine & Tobacco Research. 24(3). 395–399. 13 indexed citations
4.
Ribeiro, Carla M. P. & Bob Lubamba. (2017). Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation. International Journal of Molecular Sciences. 18(1). 118–118. 32 indexed citations
5.
Lubamba, Bob, Lisa C. Jones, Wanda K. O’Neal, Richard C. Boucher, & Carla M. P. Ribeiro. (2015). X-Box–Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages. American Journal of Respiratory and Critical Care Medicine. 192(12). 1449–1461. 51 indexed citations
6.
Leonard, Amanda, et al.. (2012). 27 Comparative variability of nasal potential difference measurements in human and mice, healthy or carrying two severe CFTR mutations. Journal of Cystic Fibrosis. 11. S62–S62. 1 indexed citations
7.
Lubamba, Bob, et al.. (2012). Cystic fibrosis: Insight into CFTR pathophysiology and pharmacotherapy. Clinical Biochemistry. 45(15). 1132–1144. 102 indexed citations
8.
Lubamba, Bob, François Huaux, Jean Lebacq, et al.. (2012). Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice. Journal of Cystic Fibrosis. 11(4). 266–273. 23 indexed citations
9.
Leonard, Anissa, Bob Lubamba, Sabrina Noël, et al.. (2012). Comparative Variability of Nasal Potential Difference Measurements in Human and Mice. DIAL (Catholic University of Leuven). 2(2). 43–56. 8 indexed citations
10.
Lubamba, Bob, Nadtha Panin, Jean Lebacq, et al.. (2011). 70 Vardenafil as anti-inflammatory drug in the treatment of cystic fibrosis lung disease. Journal of Cystic Fibrosis. 10. S18–S18. 1 indexed citations
11.
D’hooghe, Marie, et al.. (2011). 63 Resveratrol improves chloride secretion in cystic fibrosis mice homozygous for the F508del mutation. Journal of Cystic Fibrosis. 10. S17–S17. 1 indexed citations
12.
Lubamba, Bob, Jean Lebacq, Grégory Reychler, et al.. (2010). Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice. European Respiratory Journal. 37(1). 72–78. 37 indexed citations
13.
Lubamba, Bob, Jean Lebacq, Patrick Lebecque, et al.. (2009). Airway Delivery of Low-Dose Miglustat Normalizes Nasal Potential Difference in F508del Cystic Fibrosis Mice. American Journal of Respiratory and Critical Care Medicine. 179(11). 1022–1028. 41 indexed citations
14.
Lubamba, Bob, Jean Lebacq, Patrick Lebecque, et al.. (2007). Preclinical Evidence that Sildenafil and Vardenafil Activate Chloride Transport in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 177(5). 506–515. 53 indexed citations
15.
Lubamba, Bob, T. Coste, Jean Lebacq, et al.. (2007). 45* Preclinical evidence that sildenafil corrects cystic fibrosis defects. Journal of Cystic Fibrosis. 6. S11–S11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel P. Cook Breakdown of academic impact, for papers by Puay-Wah Phuan Breakdown of academic impact, for papers by Furong Yan Breakdown of academic impact, for papers by Patryk Szulakowski Breakdown of academic impact, for papers by Hiro Matsui Breakdown of academic impact, for papers by Mary Abigail S. Garcia Breakdown of academic impact, for papers by Chih-Ru Lin Breakdown of academic impact, for papers by Abdullah Akbar Breakdown of academic impact, for papers by Maria Pantelidou
Rankless by CCL
2026